1,034 results
SD
EX-1.01
TEVA
Teva- Pharmaceutical Industries Ltd.
30 May 24
Conflict minerals disclosure
4:25pm
to access affordable medicines and benefit from innovations to improve their health. Our mission is to be a global leader in generics, innovative medicines … innovative medicines portfolio and global infrastructure and scale.
As of December 31, 2023, our products generally were generic medicines, biosimilar
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
15 May 24
Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations
8:30am
, including our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline … and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development, and to sustain and focus our
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
8 May 24
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
7:01am
, fueled by robust growth in our generics business across all regions, and continued growth of our innovative brands AUSTEDO and AJOVY.”
Mr. Francis … the goals and milestones we set out to achieve on our journey to growth, including the progression of our innovative pipeline and growth drivers, as well
8-K
EX-99.1
vhwhbc8m6pw3a bz
31 Jan 24
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
61obe bp1wrr
8 Nov 23
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
7:01am
8-K
g7gtibjfk rlzmtgd2
4 Oct 23
Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment
6:05am
8-K
EX-99.1
xm1nkkf2dlfqxjo75b
4 Oct 23
Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment
6:05am
8-K
EX-99.1
bt9bwfn
28 Sep 23
Teva Announces Changes to Executive Management Team
4:05pm
8-K
EX-99.1
j0acac3
24 Aug 23
Entry into a Material Definitive Agreement
7:30am
8-K
69s6qze mvtrf
2 Aug 23
Departure of Directors or Certain Officers
4:16pm
8-K
EX-99.1
prl0ll5 bn41mp6
2 Aug 23
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
b2c8ku4a0do 1hz
8 Jun 23
Teva Concludes Nationwide Opioids Settlement Agreement
8:30am
SD
EX-1.01
2hdji7ac i0
24 May 23
Conflict minerals disclosure
12:00am
8-K
EX-99.1
pi41nulxexr74 vtjy6h
10 May 23
Results of Operations and Financial Condition
7:01am